Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2018) 56 GP22 | DOI: 10.1530/endoabs.56.GP22

1University of Cape Town, Cape Town, South Africa; 2Centre of Neuroendocrinology, University of Pretoria, Pretoria, South Africa; 3Institute of Infectious Diseases and Molecular Medicine, Cape Town, South Africa; 4Department of Medicine University of the Free State, Bloemfontein, South Africa; 5University of Oxford, Oxford, UK; 6Chemical Pathology University of Pretoria, Pretoria, South Africa; 7NHLS, Pretoria, South Africa; 8University of Stellenbosch, Cape Town, South Africa; 9Institute of Medicine Sahlgrenska, Gothenberg, Sweden.


Background: Addison’s disease is probably under-diagnosed in South Africa, given that the prevalence is considerably lower than reported in Western countries (Chabre O 2017); this is important as patients may be dying from a highly treatable condition. In addition, large populations of HIV and tuberculosis infected patients in South Africa may have some symptoms erroneously attributed to these conditions, rather than Addison’s disease. We determined the prevalence and aetiology of Addison’s disease among hospitalised HIV-infected patients.

Methods: HIV-positive patients with a CD4 count of less than 100 cells/mm3 and concurrent opportunistic infection, who were admitted to a medical ward were assessed with simultaneous early morning plasma cortisol and ACTH analysed by immunoassay (Roche Cobas 6000 platform). Where the basal cortisol was less than 550 nmol/l, a 250 μg Synacthen test was performed. Patients were excluded if they had received any steroids in the three months prior to enrolment.

Results: A total of 60 patients (23 males and 37 females) were evaluated in this interim analysis. The age median and interquartile range at presentation was 36.0 (32.0–40.0) years. The median duration of feeling unwell, prior to admission was 26.0 (14.0–60.0) days. Intercurrent pulmonary tuberculosis (TB) was diagnosed in 60% of these patients and 11 (18%) were already on antiretroviral treatment. Despite being severely ill, 37 (61%) had a basal cortisol of less than 550 nmol/l and the basal ACTH was elevated in 12%, whereas in the remainder it was in the reference range. A 250 μg Synacthen test was performed in 21 (35%). Of these four patients had an inadequate cortisol reserve at 30 min (<550 nmo/l), of whom three patients had central hypoadrenalism and one patient had primary hypoadrenalism, suggesting an overall prevalence of hypoadrenalism in this group of 6.7%. The median maximal cortisol following a Synacthen test was 697.0 (558.0–793.0) nmol/l, with at least five additional patients demonstrating an increment of less than 200 nmol/l.

Conclusions: In this severely ill patient group, at least 8% demonstrated relative adrenal insufficiency, which could contribute to the future high mortality Preliminary data indicate a relatively low prevalence of overt hypoadrenalism (6.7%), but since it is a life-threatening illness it warrants screening in the future.

Volume 56

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts